GR3004763T3 - - Google Patents

Info

Publication number
GR3004763T3
GR3004763T3 GR920401107T GR920401107T GR3004763T3 GR 3004763 T3 GR3004763 T3 GR 3004763T3 GR 920401107 T GR920401107 T GR 920401107T GR 920401107 T GR920401107 T GR 920401107T GR 3004763 T3 GR3004763 T3 GR 3004763T3
Authority
GR
Greece
Prior art keywords
plasma
blood
treated
recipient
immunoadsorbent
Prior art date
Application number
GR920401107T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3004763T3 publication Critical patent/GR3004763T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Anesthesiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GR920401107T 1984-07-19 1992-05-29 GR3004763T3 (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/632,756 US4664913A (en) 1982-05-24 1984-07-19 Method for treating plasma for transfusion

Publications (1)

Publication Number Publication Date
GR3004763T3 true GR3004763T3 (OSRAM) 1993-04-28

Family

ID=24536816

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920401107T GR3004763T3 (OSRAM) 1984-07-19 1992-05-29

Country Status (7)

Country Link
US (1) US4664913A (OSRAM)
EP (1) EP0276342B1 (OSRAM)
AT (1) ATE74282T1 (OSRAM)
AU (1) AU596392B2 (OSRAM)
DE (1) DE3778002D1 (OSRAM)
ES (1) ES2032276T3 (OSRAM)
GR (1) GR3004763T3 (OSRAM)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061237A (en) * 1985-07-02 1991-10-29 Cytomed Medizintechnik Gmbh Method of purifying whole blood
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
US5122112A (en) * 1986-11-21 1992-06-16 Imre Corporation Antigen-specific removal of circulating immune complexes
US5147289A (en) * 1990-03-29 1992-09-15 Therakos, Inc Non-specific immune system enhancement
AU667530B2 (en) * 1992-05-28 1996-03-28 New York Blood Center, Inc., The Removal of antibodies from blood-derived compositions while retaining coagulation factors
US20020182195A1 (en) * 1997-08-05 2002-12-05 Octapharma Ag Universally applicable blood plasma
EP0896824A1 (en) * 1997-08-05 1999-02-17 Octapharma Ag A universally applicable blood plasma
US8197430B1 (en) * 1998-05-22 2012-06-12 Biopheresis Technologies, Inc. Method and system to remove cytokine inhibitor in patients
US6620382B1 (en) 1998-05-22 2003-09-16 Biopheresis Technologies, Llc. Method and compositions for treatment of cancers
MXPA02003517A (es) * 1999-10-08 2004-09-10 Vi Technologies Inc Composiciones sanguineas desprovistas de isoaglutinina y metodo para elaborarlas.
US6379708B1 (en) * 1999-11-20 2002-04-30 Cytologic, Llc Method for enhancing immune responses in mammals
US8865172B2 (en) 2000-05-08 2014-10-21 Advanced Extravascular Systems, Inc. Method for reducing the number of unwanted molecules in bodily fluids
CN1207004C (zh) * 2001-04-18 2005-06-22 马建川 通用型冻干血浆及其制备方法
AU2002355846A1 (en) * 2001-08-01 2003-02-17 Anil K. Chauhan Immune complexes
WO2004071446A2 (en) * 2003-02-12 2004-08-26 Chauhan Anil K Immune complexes
AU2004298790B2 (en) * 2003-12-19 2010-04-08 Octapharma Ag A universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma
WO2005107802A2 (en) * 2004-04-30 2005-11-17 Biopheresis Technologies, Llc Method and system to remove soluble tnfr1, tnfr2, and il2 in patients
US20070065514A1 (en) * 2005-09-22 2007-03-22 Howell Mark D Method for enhancing immune responses in mammals
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
US20080075690A1 (en) * 2006-09-22 2008-03-27 Mark Douglas Howell Method for enhancing immune responses in mammals
US7776022B2 (en) * 2007-03-19 2010-08-17 Hemcon Medical Technologies Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US8449520B2 (en) * 2007-03-19 2013-05-28 HemCon Medical Technologies Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US20090107001A1 (en) * 2007-03-19 2009-04-30 Hemcon Medical Technologies, Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US20090223080A1 (en) * 2007-03-19 2009-09-10 Hemcon Medical Technologies, Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
FR3035794B1 (fr) 2015-05-06 2017-05-05 Elicityl Procede pour la purification du sang total ou d'un produit issu du sang
FR3035799B1 (fr) 2015-05-06 2017-05-05 Elicityl Support pour la purification de liquides biologiques
US10697983B2 (en) 2015-09-08 2020-06-30 Merck Patent Gmbh Methods of evaluating quality of media suitable for removing anti-A or anti-B antibodies
US10697982B2 (en) 2015-09-08 2020-06-30 Merck Patent Gmbh Methods of evaluating quality of a chromatography media which binds anti-A or anti-B antibodies
US20170066839A1 (en) 2015-09-08 2017-03-09 Merck Patent Gmbh Novel affinity chromatography media for removal of anti-a and/or anti-b antibodies
US10793327B2 (en) 2017-10-09 2020-10-06 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same
CN114127501B (zh) 2019-03-14 2023-02-17 泰尔茂比司特生物技术有限公司 多部分冻干容器及使用方法
DE102020212609B3 (de) * 2020-10-06 2022-04-07 Universität Greifswald Verfahren und Vorrichtung zur Herstellung von Universalplasma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2533440A1 (fr) * 1982-09-24 1984-03-30 Inst Nat Sante Rech Med Dispositif pour l'elimination ou la recuperation de substances biologiquement actives a partir du sang, son obtention et son utilisation
AT399095B (de) * 1986-03-27 1995-03-27 Vukovich Thomas Dr Verfahren zur auftrennung von proteinen mittels gradientenelution und vorrichtung zur durchführung des verfahrens

Also Published As

Publication number Publication date
US4664913A (en) 1987-05-12
EP0276342A1 (en) 1988-08-03
AU596392B2 (en) 1990-05-03
EP0276342B1 (en) 1992-04-01
ATE74282T1 (de) 1992-04-15
AU6804987A (en) 1988-08-04
ES2032276T3 (es) 1993-02-01
US4664913B1 (OSRAM) 1990-01-30
DE3778002D1 (de) 1992-05-07

Similar Documents

Publication Publication Date Title
US4664913B1 (OSRAM)
ATE88097T1 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
ATE59146T1 (de) Geraet zur bestrahlung von blutteilen.
DE3468326D1 (en) System for extracorporeal blood treatment
IT8324139A0 (it) Innesto vascolare e metodo per rifornire il sangue.
EP0172018A3 (en) Method and apparatus for treatment to remove immunoreactive substances from blood
YU42859B (en) Apparatus for blood gathering and reinfusion
ES533098A0 (es) Un procedimiento para el tratamiento de sangre completa, preparandola para el recuento de particulas y la determinacion de la hemoglobina.
EP0583691A3 (en) Method and device for a continuous treatment of a cellular suspension
DE3572179D1 (en) Blood coagulation inhibiting proteins, process for preparing them and their use
EP0168801A3 (en) Apparatus for separating proteins from blood plasma, and agent therefor
ZA897858B (en) Family of high affinity,modified antibodies for cancer treatment
EP0376251A3 (en) An anticoagulant substance obtained from urine
PL247999A1 (en) Method of obtaining proteinous concentrates and nutrients from animal blood
EP0154522A3 (en) Method for sphering and fixing whole blood erythrocytes
DE3260830D1 (en) Process for the manufacture of globin or blood cell protein and heme from hemoglobin
HUT59724A (en) Process for producing new thrombosolving material
EP0287028A3 (en) Method of separating activated human protein c
EP0116628A4 (en) 1-ACYL-3-PYRIDYLMETHYLGUANIDINE AND THEIR USE AS AN ANI-HYPERTENSIVE.
YU172784A (en) Process for treating of animal blood and its parts
FI871078A7 (fi) Menetelmä ja seos bronkospastisten hengitystietautien hoitamiseksi.
AU8459882A (en) Human leukocyte pepsin-like enzyme, and a therapeutic agent containing said enzyme as effective ingredient for treating allergic disorder, immune complex disease, and tumor
PL244394A1 (en) Method of processing whole animal blood
DE3363054D1 (en) Method for obtaining solid or gel-like protein concentrates from blood or plasma of animal origin
GB2248193B (en) Device and method for depletion of the leukocyte content of blood and blood components